Cronos Group Inc. (CRON) is a principal investment firm.
The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations "MMPR".
The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate.
It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control.
Shares have formed a bullish "flag" after Altria Group (MO) took a stake in the company. On Dec. 7, the firm said it would invest a $1.8 billion stake in Cronos Group. The news sent shares higher. We expect shares to keep moving higher.
Entry Point: $12.80
Stop Loss: $12.10
Trading Range: $5.12 - $15.30
Target Price: $14.08
CRON closed at $14.54